Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography

Detalhes bibliográficos
Autor(a) principal: Qu, Gonglin
Data de Publicação: 2018
Outros Autores: Xu, Liang, Zhang, Wenjie, Ying, Xixiang
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/159274
Resumo: The novel alkaloid, oleracimine, presented remarkable anti-inflammatory bioactivity, and therefore, its pharmacokinetics was investigated in rat plasma after intravenous and oral administration by using a rapid ultra-high-performance liquid chromatography (UHPLC) method with UV detection at 270 nm. The analysis was performed on a shim-pack ODS column (75 mm×2 mm, 1.6 µm particle size, Shimadzu, Japan) column using isocratic elution with a mobile phase consisting of methanol-water (62:38, v/v) within 3 min. The results indicated that oleracimine was rapidly distributed with Tmax for 11.7 min after oral administration, which presented the double-peak phenomenon in the pharmacokinetic profile with a higher oral absolute bioavailability of 55.1% ± 7.83%.
id USP-31_208bf3d675a9de77fcab625ec46414db
oai_identifier_str oai:revistas.usp.br:article/159274
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatographyPortulaca oleracea L./OleracimineUltra-High-Performance Liquid Chromatography/Rat plasmaPharmacokineticsThe novel alkaloid, oleracimine, presented remarkable anti-inflammatory bioactivity, and therefore, its pharmacokinetics was investigated in rat plasma after intravenous and oral administration by using a rapid ultra-high-performance liquid chromatography (UHPLC) method with UV detection at 270 nm. The analysis was performed on a shim-pack ODS column (75 mm×2 mm, 1.6 µm particle size, Shimadzu, Japan) column using isocratic elution with a mobile phase consisting of methanol-water (62:38, v/v) within 3 min. The results indicated that oleracimine was rapidly distributed with Tmax for 11.7 min after oral administration, which presented the double-peak phenomenon in the pharmacokinetic profile with a higher oral absolute bioavailability of 55.1% ± 7.83%.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15927410.1590/s2175-97902018000417242Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17242Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17242Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e172422175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/159274/154080Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccessQu, GonglinXu, LiangZhang, WenjieYing, Xixiang2019-06-24T20:15:38Zoai:revistas.usp.br:article/159274Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-06-24T20:15:38Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
title Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
spellingShingle Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
Qu, Gonglin
Portulaca oleracea L./Oleracimine
Ultra-High-Performance Liquid Chromatography/Rat plasma
Pharmacokinetics
title_short Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
title_full Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
title_fullStr Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
title_full_unstemmed Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
title_sort Pharmacokinetics of oleracimine in rats by ultra-high-performance liquid chromatography
author Qu, Gonglin
author_facet Qu, Gonglin
Xu, Liang
Zhang, Wenjie
Ying, Xixiang
author_role author
author2 Xu, Liang
Zhang, Wenjie
Ying, Xixiang
author2_role author
author
author
dc.contributor.author.fl_str_mv Qu, Gonglin
Xu, Liang
Zhang, Wenjie
Ying, Xixiang
dc.subject.por.fl_str_mv Portulaca oleracea L./Oleracimine
Ultra-High-Performance Liquid Chromatography/Rat plasma
Pharmacokinetics
topic Portulaca oleracea L./Oleracimine
Ultra-High-Performance Liquid Chromatography/Rat plasma
Pharmacokinetics
description The novel alkaloid, oleracimine, presented remarkable anti-inflammatory bioactivity, and therefore, its pharmacokinetics was investigated in rat plasma after intravenous and oral administration by using a rapid ultra-high-performance liquid chromatography (UHPLC) method with UV detection at 270 nm. The analysis was performed on a shim-pack ODS column (75 mm×2 mm, 1.6 µm particle size, Shimadzu, Japan) column using isocratic elution with a mobile phase consisting of methanol-water (62:38, v/v) within 3 min. The results indicated that oleracimine was rapidly distributed with Tmax for 11.7 min after oral administration, which presented the double-peak phenomenon in the pharmacokinetic profile with a higher oral absolute bioavailability of 55.1% ± 7.83%.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159274
10.1590/s2175-97902018000417242
url https://www.revistas.usp.br/bjps/article/view/159274
identifier_str_mv 10.1590/s2175-97902018000417242
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159274/154080
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17242
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17242
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17242
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913864925184